Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Interferon Biosimilar market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Interferon Biosimilarmarket, defines the market attractiveness level of Interferon Biosimilar market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Interferon Biosimilar industry, describes the types of Interferon Biosimilar market, the applications of major players and the market size, and deeply analyzes the current situation of the global Interferon Biosimilar market and the development prospects and opportunities of Interferon Biosimilar industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Interferon Biosimilar market in Chapter 13.
By Player:
Merck
Amgen
Roche
Bayer
Zydus Cadila
Nanogen
3sbio
PROBIOMED
Rhein Minapharm Biogenetics
Biosidus
Amega Biotech
Schering Plough
By Type:
Long-lasting Type
Ordinary Type
By End-User:
Hepatitis C
Hepatitis B
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Interferon Biosimilar Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Interferon Biosimilar Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Interferon Biosimilar Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Interferon Biosimilar Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Interferon Biosimilar Market Analysis and Outlook to 2022
-
7.1 Global Interferon Biosimilar Consumption (2017-2022)
-
7.2 United States Interferon Biosimilar Consumption (2017-2022)
-
7.3 Europe Interferon Biosimilar Consumption (2017-2022)
-
7.4 China Interferon Biosimilar Consumption (2017-2022)
-
7.5 Japan Interferon Biosimilar Consumption (2017-2022)
-
7.6 India Interferon Biosimilar Consumption (2017-2022)
-
7.7 South Korea Interferon Biosimilar Consumption (2017-2022)
8 Region and Country-wise Interferon Biosimilar Market Analysis and Outlook to 2028
-
8.1 Global Interferon Biosimilar Consumption Forecast (2022-2028)
-
8.2 United States Interferon Biosimilar Consumption Forecast (2022-2028)
-
8.3 Europe Interferon Biosimilar Consumption Forecast (2022-2028)
-
8.4 China Interferon Biosimilar Consumption Forecast (2022-2028)
-
8.5 Japan Interferon Biosimilar Consumption Forecast (2022-2028)
-
8.6 India Interferon Biosimilar Consumption Forecast (2022-2028)
-
8.7 South Korea Interferon Biosimilar Consumption Forecast (2022-2028)
9 Global Interferon Biosimilar Market Outlook by Types and Applications to 2022
-
9.1 Global Interferon Biosimilar Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Long-lasting Type Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Ordinary Type Consumption and Growth Rate (2017-2022)
-
9.2 Global Interferon Biosimilar Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hepatitis C Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hepatitis B Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Other Consumption and Growth Rate (2017-2022)
10 Global Interferon Biosimilar Market Outlook by Types and Applications to 2028
-
10.1 Global Interferon Biosimilar Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Long-lasting Type Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Ordinary Type Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Interferon Biosimilar Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hepatitis C Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hepatitis B Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Interferon Biosimilar Import and Export Analysis (Top 5 Countries)
-
11.1 Global Interferon Biosimilar Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Interferon Biosimilar Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Interferon Biosimilar Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Interferon Biosimilar Market Competitive Analysis
-
14.1 Merck
-
14.1.1 Merck Company Details
-
14.1.2 Merck Interferon Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Merck Interferon Biosimilar Product and Service
-
14.2 Amgen
-
14.2.1 Amgen Company Details
-
14.2.2 Amgen Interferon Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Amgen Interferon Biosimilar Product and Service
-
14.3 Roche
-
14.3.1 Roche Company Details
-
14.3.2 Roche Interferon Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Roche Interferon Biosimilar Product and Service
-
14.4 Bayer
-
14.4.1 Bayer Company Details
-
14.4.2 Bayer Interferon Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Bayer Interferon Biosimilar Product and Service
-
14.5 Zydus Cadila
-
14.5.1 Zydus Cadila Company Details
-
14.5.2 Zydus Cadila Interferon Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Zydus Cadila Interferon Biosimilar Product and Service
-
14.6 Nanogen
-
14.6.1 Nanogen Company Details
-
14.6.2 Nanogen Interferon Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Nanogen Interferon Biosimilar Product and Service
-
14.7 3sbio
-
14.7.1 3sbio Company Details
-
14.7.2 3sbio Interferon Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 3sbio Interferon Biosimilar Product and Service
-
14.8 PROBIOMED
-
14.8.1 PROBIOMED Company Details
-
14.8.2 PROBIOMED Interferon Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 PROBIOMED Interferon Biosimilar Product and Service
-
14.9 Rhein Minapharm Biogenetics
-
14.9.1 Rhein Minapharm Biogenetics Company Details
-
14.9.2 Rhein Minapharm Biogenetics Interferon Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Rhein Minapharm Biogenetics Interferon Biosimilar Product and Service
-
14.10 Biosidus
-
14.10.1 Biosidus Company Details
-
14.10.2 Biosidus Interferon Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Biosidus Interferon Biosimilar Product and Service
-
14.11 Amega Biotech
-
14.11.1 Amega Biotech Company Details
-
14.11.2 Amega Biotech Interferon Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Amega Biotech Interferon Biosimilar Product and Service
-
14.12 Schering Plough
-
14.12.1 Schering Plough Company Details
-
14.12.2 Schering Plough Interferon Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Schering Plough Interferon Biosimilar Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Interferon Biosimilar
-
Figure Interferon Biosimilar Picture
-
Table Global Interferon Biosimilar Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Interferon Biosimilar Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Interferon Biosimilar Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Interferon Biosimilar Consumption by Country (2017-2022)
-
Figure United States Interferon Biosimilar Consumption and Growth Rate (2017-2022)
-
Table Europe Interferon Biosimilar Consumption and Growth Rate (2017-2022)
-
Figure China Interferon Biosimilar Consumption and Growth Rate (2017-2022)
-
Figure Japan Interferon Biosimilar Consumption and Growth Rate (2017-2022)
-
Figure India Interferon Biosimilar Consumption and Growth Rate (2017-2022)
-
Figure South Korea Interferon Biosimilar Consumption and Growth Rate (2017-2022)
-
Figure Global Interferon Biosimilar Consumption Forecast by Country (2022-2028)
-
Figure United States Interferon Biosimilar Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Interferon Biosimilar Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Interferon Biosimilar Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Interferon Biosimilar Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Interferon Biosimilar Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Interferon Biosimilar Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Long-lasting Type Consumption and Growth Rate (2017-2022)
-
Figure Global Ordinary Type Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis C Consumption and Growth Rate (2017-2022)
-
Figure Global Hepatitis B Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Long-lasting Type Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ordinary Type Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hepatitis C Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hepatitis B Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Interferon Biosimilar Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Interferon Biosimilar Export by Region (Top 5 Countries) (2017-2028)
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Interferon Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Interferon Biosimilar Product and Service
-
Table Amgen (Foundation Year, Company Profile and etc.)
-
Table Amgen Interferon Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Interferon Biosimilar Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Interferon Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Interferon Biosimilar Product and Service
-
Table Bayer (Foundation Year, Company Profile and etc.)
-
Table Bayer Interferon Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer Interferon Biosimilar Product and Service
-
Table Zydus Cadila (Foundation Year, Company Profile and etc.)
-
Table Zydus Cadila Interferon Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table Zydus Cadila Interferon Biosimilar Product and Service
-
Table Nanogen (Foundation Year, Company Profile and etc.)
-
Table Nanogen Interferon Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table Nanogen Interferon Biosimilar Product and Service
-
Table 3sbio (Foundation Year, Company Profile and etc.)
-
Table 3sbio Interferon Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table 3sbio Interferon Biosimilar Product and Service
-
Table PROBIOMED (Foundation Year, Company Profile and etc.)
-
Table PROBIOMED Interferon Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table PROBIOMED Interferon Biosimilar Product and Service
-
Table Rhein Minapharm Biogenetics (Foundation Year, Company Profile and etc.)
-
Table Rhein Minapharm Biogenetics Interferon Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table Rhein Minapharm Biogenetics Interferon Biosimilar Product and Service
-
Table Biosidus (Foundation Year, Company Profile and etc.)
-
Table Biosidus Interferon Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table Biosidus Interferon Biosimilar Product and Service
-
Table Amega Biotech (Foundation Year, Company Profile and etc.)
-
Table Amega Biotech Interferon Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amega Biotech Interferon Biosimilar Product and Service
-
Table Schering Plough (Foundation Year, Company Profile and etc.)
-
Table Schering Plough Interferon Biosimilar Sales, Price, Value and Gross Profit (2017-2022)
-
Table Schering Plough Interferon Biosimilar Product and Service
-
